Advik Laboratories Ltd.
Snapshot View

1.91 ▼0%

28 November 2022, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.advikindia.com
Market Cap 3.65 Cr.
Enterprise Value(EV) 10.03 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.17 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 35.40 Trailing Twelve Months Ending 2022-09
Book Value / Share 1.75 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.09 Calculated using Price: 1.91
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.91 Cr. 19,111,400 Shares
FaceValue 10
Company Profile
Advik Laboratories has been set up by V K Jain, a qualified production chemist with over 20 years experience in pharmaceutical products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
1 Month
+4.95%
3 Month
+9.77%
6 Month
+25.66%
1 Year
+50.39%
2 Year
+430.56%
5 Year
-63.34%
10 Year
-63.83%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 3.24 -4.03 -6.79 -48.30 -7.74 -12.28 -13.04 -71.73 -3.64
Return on Capital Employed (%) 8.13 0.59 -4.23 -33.90 -5.91 -7.76 -8.08 -36.90 -9.64
Return on Assets (%) 1.45 -2.01 -3.91 -29.85 -4.32 -6.79 -6.87 -31.87 -1.32

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 20 19 19 12 11 10 8 4 4 3
Non Curr. Liab. 4 3 2 1 1 1 1 1 0 0
Curr. Liab. 10 10 7 8 8 7 7 7 6 7
Minority Int.
Equity & Liab. 35 32 29 21 19 18 16 11 10 10
Non Curr. Assets 16 15 15 14 13 12 11 9 8 8
Curr. Assets 19 17 14 7 7 5 5 2 2 2
Misc. Exp. not W/O
Total Assets 35 32 29 21 19 18 16 11 10 10

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 30 12 1 3 4 1 0 0
Other Income 0 0 0 0 0 0 0
Total Income 30 12 1 3 4 1 0 0 0 0
Total Expenditure -27 -11 -2 -10 -5 -2 -1 -4 -1 -1
PBIDT 3 1 0 -7 0 -1 -1 -4 0 -1
Interest -1 -1 0
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 0
Taxation -1 0 0 0 0 0 0 0 1 1
Exceptional Items
PAT 0 -1 -1 -7 -1 -1 -1 -4 0 0
Adjusted EPS 0 0 -1 -4 0 -1 -1 -2 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 5 2 1 0 0 1 0 -1 -4
Cash Fr. Inv. 0 -6 0 0 1 0 0 0 2 0
Cash Fr. Finan. 0 2 -2 -1 -1 0 0 -1 4
Net Change 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 35.89 35.89 35.89 35.89 35.89 35.89 35.89 35.89 35.89
Public 64.11 64.11 64.11 64.11 64.11 64.11 64.11 64.11 64.11
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 71.16 71.16 16.04 16.04 16.04 16.04 16.04 16.04 16.04

Announcements View Details >>

Fri, 25 Nov 2022
Disclosure Of Related Party Transaction For The Half Year Ended September 30 2022 Pursuant To Regulation 23(9) Of The SEBI (LODR) Regulation 2015
As per the requirements of Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find enclosed herewith the disclosure of Related Party Transactions for the half year ended 30thSeptember 2022 in the format prescribed by the Securities and Exchange Board of India vide Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22 2022. We hope that you will find the above in order. We request you to take the above document in your records.
Wed, 16 Nov 2022
Board Meeting Outcome for Clarification/ Additional Details Submitted For Corporate Announcement Filed Under Regulation 30Of SEBI (LODR) Regulations 2015.
We wish to inform you that the Board Meeting held at 12th November 2022 was commenced at 01:30 P.M andthe same was concluded at 02:48 P.M.
Mon, 14 Nov 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations 2015 please find enclosed herewith a copy of newspaper publication w.r.t Un-audited Financial Results for the quarter/ half year ended 30th September 2022 published on 13th November 2022 in Financial Express English Newspaper & Jansatta Hindi Newspaper All India edition. We hope that you will find the above in order. This is for your information and records please .

Technical Scans View Details >>

Mon, 28 Nov 2022
Opening at High Opening at High
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Increase 6 Months High Increase 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,530.84 1,040.00 -0.6%
Cipla Ltd. 89,936.23 1,114.35 -0.9%
Divi's Laboratories Ltd. 89,761.56 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. 75,098.21 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. 70,043.98 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. 54,931.39 1,623.05 -1.2%
Max Healthcare Institute Ltd. 43,491.25 448.10 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.50 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 35.23 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.99 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 24.23 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 83.18 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.92 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 46.09 448.10 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.68 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 4.13 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.40 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.63 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.67 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.02 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.29 448.10 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 448.10 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 448.10 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 448.10 -0.9%

FAQ's On Advik Laboratories Ltd.

What is Advik Lab share price?

Can I buy Advik Lab shares now?

What is the Market Cap of Advik Lab?

What are the key metrics to analyse Advik Lab?

What is the 52 Week High and Low of Advik Lab?